Goldman Sachs Group Inc

Holdings History for FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Symbol: FATE on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 2.27M shares
Security Ownership: 2%

Shares, Excluding Options vs Price

Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE)

2025-08-14 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.27M shares of FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE). This represents 2% percent ownership of the company. In their previous filing dated 2025-05-09, GOLDMAN SACHS GROUP INC had reported owning 8.49M shares, indicating a decrease of -73.2% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
THE GOLDMAN SACHS GROUP, INC.	2%	-77.1%	$2.55M	2.27M	-6,213,200	-73.2%	$1.12	13G/A	6/30/2025	14 Aug 2025 11:30:17
THE GOLDMAN SACHS GROUP, INC.	7.4%		$11.5M	8.49M			$1.35	13G	3/31/2025	9 May 2025 12:27:11

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	0%	$1.87M	1.49M	-1,025,269	-40.8%	$1.26	Q3 2025
6/30/2025	0%	+0%	$2.81M	2.51M	+52,702	+2.14%	$1.12	Q2 2025
3/31/2025	0%	0%	$1.94M	2.46M	-17,440		$0.79	Q1 2025
12/31/2024	0%	0%	$4.09M	2.48M	-346,989	-12.3%	$1.65	Q4 2024
9/30/2024	0%	+0%	$9.88M	2.82M	+474,849	+20.2%	$3.50	Q3 2024
6/30/2024	0%	+0%	$7.7M	2.35M	+336,296	+16.7%	$3.28	Q2 2024
3/31/2024	0%	+0%	$14.8M	2.01M	+1,421,265	+240%	$7.34	Q1 2024
12/31/2023	0%	+0%	$2.21M	591K	+96,527	+19.5%	$3.74	Q4 2023
9/30/2023	0%	0%	$1.05M	494K	-590,367	-54.4%	$2.12	Q3 2023
6/30/2023	0%	0%	$5.16M	1.08M	-243,828	-18.4%	$4.76	Q2 2023
3/31/2023	0%	+0%	$7.57M	1.33M	+518,625	+64%	$5.70	Q1 2023
12/31/2022	0%	0%	$8.17M	810K	-231,691	-22.2%	$10.09	Q4 2022
9/30/2022	0.01%	0%	$23.3M	1.04M	-42,943	-3.96%	$22.41	Q3 2022
6/30/2022	0.01%	+0.01%	$26.9M	1.08M	+858,193	+379%	$24.78	Q2 2022
3/31/2022	0%	0%	$8.78M	226K	-180,694	-44.4%	$38.77	Q1 2022
12/31/2021	0.01%	0%	$23.8M	407K	-163,752	-28.7%	$58.51	Q4 2021
9/30/2021	0.01%	0%	$33.8M	571K	-22,519	-3.79%	$59.27	Q3 2021
6/30/2021	0.01%	-0.01%	$51.5M	593K	-226,100	-27.6%	$86.79	Q2 2021
3/31/2021	0.02%	+0%	$67.6M	820K	+44,128	+5.69%	$82.45	Q1 2021
12/31/2020	0.02%	-0.02%	$70.5M	775K	-533,553	-40.8%	$90.93	Q4 2020
9/30/2020	0.02%	+0%	$52.3M	1.31M	+265,771	+25.5%	$39.97	Q3 2020
6/30/2020	0.01%	+0%	$35.8M	1.04M	+298,727	+40.1%	$34.31	Q2 2020
3/31/2020	0.01%	+0%	$16.5M	744K	+69,032	+10.2%	$22.21	Q1 2020
12/31/2019	0%	+0%	$13.2M	675K	+218,850	+47.9%	$19.57	Q4 2019
9/30/2019	0%	+0%	$7.09M	457K	+12,471	+2.81%	$15.53	Q3 2019
6/30/2019	0%	+0%	$9.02M	444K	+65,266	+17.2%	$20.30	Q2 2019
3/31/2019	0%	+0%	$6.66M	379K	+33,892	+9.82%	$17.57	Q1 2019
12/31/2018	0%	+0%	$4.43M	345K	+245,281	+246%	$12.83	Q4 2018
9/30/2018	0%	+0%	$1.62M	99.7K	+72,379	+265%	$16.28	Q3 2018
6/30/2018	0%	+0%	$310K	27.3K	+27,298	NEW	$11.36	Q2 2018
3/31/2018		0%	$0	0	-50,966	-100%		Q1 2018
12/31/2017	0%	0%	$311K	51K	-75,260	-59.6%	$6.10	Q4 2017
9/30/2017	0%	+0%	$500K	126K	+14,451	+12.9%	$3.96	Q3 2017
6/30/2017	0%	0%	$362K	112K	-32,278	-22.4%	$3.24	Q2 2017
3/31/2017	0%	+0%	$655K	144K	+119,200	+480%	$4.55	Q1 2017
12/31/2016	0%	0%	$62K	24.9K	-10,564	-29.8%	$2.49	Q4 2016
9/30/2016	0%	0%	$111K	35.4K	-549	-1.53%	$3.13	Q3 2016
6/30/2016	0%	0%	$61K	36K	-137,958	-79.3%	$1.70	Q2 2016
3/31/2016	0%	+0%	$313K	174K	+147,233	+552%	$1.80	Q1 2016
12/31/2015	0%	+0%	$90K	26.7K	+11,894	+80.4%	$3.37	Q4 2015
9/30/2015	0%	+0%	$79K	14.8K	+2,547	+20.8%	$5.34	Q3 2015
6/30/2015	0%	0%	$79K	12.3K	-24,763	-66.9%	$6.45	Q2 2015
3/31/2015	0%	0%	$181K	37K	-36,423	-49.6%	$4.89	Q1 2015
12/31/2014	0%	0%	$369K	73.4K	-10,256	-12.3%	$5.02	Q4 2014
9/30/2014	0%	+0%	$427K	83.7K	+15,815	+23.3%	$5.10	Q3 2014
6/30/2014	0%	+0%	$428K	67.9K	+41,567	+158%	$6.31	Q2 2014
3/31/2014	0%	0%	$256K	26.3K	-14,681	-35.8%	$9.73	Q1 2014
12/31/2013	0%		$257K	41K			$6.27	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.